Skip to the content

AML Thecosystem

Acute Myeloid Leukaemia

£150 per month

It’s all about seeing who’s who, what they’ve done, who they work with, how they influence.

What’s in a Thecosystem?

Hundreds of guidelines, regulatory & reimbursement reviews and learned societies. 

Thousands of people, experts, influencers, publications, events and clinical trials.

See how everything connects

All the information you need, in one place.
Up to date and instantly useful.

 

People

Over 3600 experts

  • Find profiles of thousands of the experts actively shaping AML
  • Explore professional networks
  • Academics, physicians, policy makers, economists, even patients
  • High-quality information and insights traditionally reserved for senior executives
  • Accurate, complete, up-to-date, referenced and connected

Guidelines

Over 50 including:

  • Acute Myeloid Leukemia, version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
  • Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy.
  • Guidelines on the treatment of acute myeloid leukemia: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associacao Medica Brasileira - 2015.
  • NSW Model of Care for Acute Myeloid Leukaemia
  • 造血器腫瘍診療ガイドライン (Guidelines for clinical practice of hematological malignancies)

Regulatory & Reimbursement Organisations

19 including:

  • U.S. Food and Drug Administration (FDA)
  • European Medicines Agency (EMA)
  • Center for Drug Evaluation, Taiwan
  • Ministry of Health of the People's Republic of China
  • National Institute for Health and Care Excellence (NICE)

Professional Associations

Over 300 including:

  • American Society of Hematology
  • Asia Pacific Hematology Consortium (APHCON)
  • American Society for Blood and Marrow Transplantation
  • Deutsche Gesellschaft für Hämatologie und Onkologie
  • European Hematology Association

Patient Advocacy Groups

Over 60 including:

  • Leukemia & Lymphoma Society
  • The Bone Marrow Foundation
  • Jose-Carreras Foundation
  • Associazione Italiana contro le Leucemie
  • Deutsche Leukämie- & Lymphom-Hilfe e.V.

Journals

Over 600 including:

  • American Journal of Hematology
  • Blood
  • Asia-Pacific Blood and Marrow Transplantation
  • British Journal of Haematology
  • European Journal of Haematology

Conferences

Over 600 including:

  • Acute Leukemia Forum 2019
  • 60th Annual Meeting of American Society of Hematology
  • 23rd Congress of European Hematology Association
  • 2018 中国血液病大会 (2018 Chinese Hematology Conference)
  • 58차 대한혈액학회추계학술대회 (58th Autumn Meeting of Korean Society of Hematology) (KSH)

Clinical Trials

Over 1400 including:

  • Venetoclax and Quizartinib in Treating Patients with FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
  • Trial of Eltrombopag During Consolidation Therapy in Adults with AML in Complete Remission
  • Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants with High-Risk Acute Leukemia or Myelodysplastic Syndrome
  • Study of Vosaroxin and Decitabine in Older Patients with Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
  • Study of KB004 in Subjects with Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

AML Thecosystem

Acute Myeloid Leukaemia

£150 per month